🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 6

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 6 of 9
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Sep 21, 2025 at 11:39 PM#26

The figures, for anyone assembling their own picture. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

45 18LindaRN_retired, tommy_boulder, hyun_seoul and 42 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Oct 1, 2025 at 1:54 PM#27

One thing that is still open after traveltech_sara’s answer:

Was that from a primary source or from a summary of one?

46 19Dr.RheumBOS, greg_boulder, quinn_sf and 43 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Oct 11, 2025 at 4:14 AM#28
BiostatsBrad said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

47 20cory_ATX, lori_vegas, Dr.PulmRoch and 44 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Oct 20, 2025 at 6:40 PM#29
BiostatsBrad said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

Last edited: Oct 20, 2025 at 7:40 PM
48 21dan_philly, MeganSA_TX, LarryQC_SD and 45 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Oct 30, 2025 at 9:11 AM#30

OP back with an update, since a thread like this is useless without one.

For the archive: it took about six weeks rather than the two I expected, and the difference between those two numbers was the whole of my problem.

Last edited: Oct 30, 2025 at 3:11 PM
20 18kim_atl_prep, sarah_TO, wendy_avl and 17 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register